• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿弗马宁A对肠道二肽转运的抑制作用。

Inhibitory effect of arphamenine A on intestinal dipeptide transport.

作者信息

Enjoh M, Hashimoto K, Arai S, Shimizu M

机构信息

Department of Applied Biological Chemistry, Graduate School of Agriculture and Life Sciences, University of Tokyo, Japan.

出版信息

Biosci Biotechnol Biochem. 1996 Nov;60(11):1893-5. doi: 10.1271/bbb.60.1893.

DOI:10.1271/bbb.60.1893
PMID:8987870
Abstract

Arphamenine A, an Arg-Phe analog without a peptide bond, has been reported to be a possible inhibitor of the peptide transporter [H. Daniel and S.A. Adibi, FASEB J., 8, 753 (1994)]. The present study demonstrated that arphamenine A is not a real inhibitor, but is a substrate for the transporter, being transported transepithelially under a proton gradient. The substrate specificity of the peptide transporter was wider than expected.

摘要

无肽键的精氨酸-苯丙氨酸类似物阿法美宁A据报道可能是肽转运体的抑制剂[H. 丹尼尔和S.A. 阿迪比,《美国实验生物学会联合会杂志》,8,753(1994)]。本研究表明,阿法美宁A并非真正的抑制剂,而是该转运体的底物,在质子梯度下可进行跨上皮转运。肽转运体的底物特异性比预期的更广泛。

相似文献

1
Inhibitory effect of arphamenine A on intestinal dipeptide transport.阿弗马宁A对肠道二肽转运的抑制作用。
Biosci Biotechnol Biochem. 1996 Nov;60(11):1893-5. doi: 10.1271/bbb.60.1893.
2
Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.阿昔洛韦二肽酯前药与肠道寡肽转运体的相互作用:对人肠上皮细胞系Caco-2中甘氨酰肌氨酸转运的竞争性抑制
J Pharmacol Exp Ther. 2003 Feb;304(2):781-91. doi: 10.1124/jpet.102.044313.
3
Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.通过质子偶联氨基酸转运蛋白 PAT1(SLC36A1)的肠道药物转运被 Gly-X(aa)二肽抑制。
Mol Pharm. 2012 Sep 4;9(9):2761-9. doi: 10.1021/mp300345e. Epub 2012 Aug 13.
4
Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).神经肽血管活性肠肽(VIP)对肠道二肽转运的抑制作用是通过人肠上皮样细胞系(Caco-2)中的VPAC1受体产生的一种抗吸收效应。
Br J Pharmacol. 2003 Feb;138(4):564-73. doi: 10.1038/sj.bjp.0705049.
5
A novel inhibitor of the mammalian peptide transporter PEPT1.一种新型的哺乳动物肽转运体PEPT1抑制剂。
Biochemistry. 2001 Apr 10;40(14):4454-8. doi: 10.1021/bi0026371.
6
Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.口服头孢菌素通过H⁺/二肽共转运体的转运及转运活性在兔离体肠上皮细胞中的分布
J Pharmacol Exp Ther. 1995 Jan;272(1):63-9.
7
Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent.Caco-2 细胞单层中的基底外侧甘氨酰肌氨酸(Gly-Sar)转运是 pH 依赖性的。
J Pharm Pharmacol. 2013 Jul;65(7):970-9. doi: 10.1111/jphp.12061. Epub 2013 Mar 28.
8
Kinetics of glycylsarcosine transport by isolated chicken intestinal epithelial cells.
Rev Esp Fisiol. 1989 Dec;45(4):373-6.
9
Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.二肽与荧光染料的共轭作用增强了其对人肠道Caco-2细胞中二肽转运体(PEPT1)的亲和力。
Bioconjug Chem. 1999 Jan-Feb;10(1):24-31. doi: 10.1021/bc980049i.
10
Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.伐昔洛韦:肠道和肾脏肽转运体PEPT1和PEPT2的底物。
Biochem Biophys Res Commun. 1998 May 19;246(2):470-5. doi: 10.1006/bbrc.1998.8628.

引用本文的文献

1
Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.POT 超家族(尤其是 PepT1)的功能、调节作用及其在炎症性肠病中的病理生理相关性。
Compr Physiol. 2018 Mar 25;8(2):731-760. doi: 10.1002/cphy.c170032.
2
Targeted prodrug design to optimize drug delivery.靶向前药设计以优化药物递送。
AAPS PharmSci. 2000;2(1):E6. doi: 10.1208/ps020106.
3
Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport?
肠道小肽载体的结构-转运关系:肽键的羰基与转运有关吗?
Pharm Res. 1999 Jan;16(1):62-8. doi: 10.1023/a:1018866611555.
4
Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.肠道和肾脏肽转运体对δ-氨基乙酰丙酸的转运及其生理和临床意义。
J Clin Invest. 1998 Jun 15;101(12):2761-7. doi: 10.1172/JCI1909.